Skip to main content
TDSPHARM Co., Ltd. logo

TDSPHARM Co., Ltd. — Investor Relations & Filings

Ticker · 464280 ISIN · KR7464280007 KO Manufacturing
Open in API
Filings indexed 56 across all filing types
Latest filing 2026-05-14 Interim / Quarterly Rep…
Country KR South Korea
Listing KO 464280

About TDSPHARM Co., Ltd.

http://tdspharm.gobizkorea.com/

TDSPHARM Co., Ltd. is a pharmaceutical company specializing in the research, development, and manufacturing of Transdermal Drug Delivery Systems (TDDS), where active ingredients are absorbed through the skin. The company focuses on creating safe and effective medicinal products through dedicated R&D efforts. Its product portfolio includes a variety of TDDS-based items such as medical cataplasmas, plasters, and patches for applications like pain relief and antibiotic delivery. In addition to its core pharmaceutical business, TDSPHARM also develops and manufactures Over-The-Counter (OTC) medicines and cosmetic products, aiming to provide a wide selection of accessible healthcare solutions.

Recent filings

Filing Released Lang Actions
분기보고서 (2026.03)
Interim / Quarterly Report Classification · 95% confidence The document is titled “분기보고서” (Quarterly Report) for the 25th term covering 2026-01-01 to 2026-03-31, includes detailed financial statements, business overview, sales breakdown, risk management, and actual financial data and tables. It is the full interim/quarterly report itself, not just an announcement. Therefore, it is classified as an Interim / Quarterly Report. Q1 2026
2026-05-14 Korean
주주총회소집결의 (임시주주총회)
Regulatory Filings
2026-04-30 Korean
주주명부폐쇄기간또는기준일설정
Regulatory Filings
2026-04-30 Korean
[기재정정]정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a disclosure of the corrected results of the regular shareholders’ meeting, including detailed voting outcomes on each agenda item, financial statement approvals, board appointments, and related resolution data. This aligns with the definition for “Declaration of Voting Results & Voting Rights Announcements” (Code: DVA), which covers official results from shareholder votes at any general meeting.
2026-03-30 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 98% confidence The document provides detailed voting outcomes for each agenda item at the Annual General Meeting held on 2026-03-25, including approval results, percentages, and resolutions on financial statements, director and auditor elections, capital measures, and other shareholder proposals. This matches the definition of a Declaration of Voting Results & Voting Rights Announcement.
2026-03-25 Korean
[기재정정]주주총회소집공고
Proxy Solicitation & Information Statement Classification · 92% confidence The document is a formal notice of convocation (‘소집공고’) for the 24th regular shareholders’ meeting, providing the meeting date, agenda, management reference materials, proxy voting instructions, and electronic voting details. This type of pre‐meeting communication, which requests votes and furnishes detailed information to shareholders, aligns with a Proxy Solicitation & Information Statement (PSI).
2026-03-23 Korean

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.